Clinical Trial Update: Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery

View source ↗

Summary

Aesculap AG is conducting a clinical trial comparing Novosyn CHD with Polyglactin 910 suture for closing wounds after emergency or elective laparotomy or laparo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Surgical Site Infection

Drugs mentioned

• Novosyn CHD (polyglactin 910)
• Polyglactin 910 Suture (polyglactin 910)

Snippet

Sponsor: Aesculap AG | Conditions: Surgical Site Infection | Status: RECRUITING